Le Lézard
Classified in: Health
Subjects: PDT, MAT

KASSIR PLASTIC SURGERY PRESENTS FACELIFT MASTER COURSE


Experience Advanced Facial Rejuvenation Techniques with Dr. Ramtin Kassir and Distinguished Faculty

NEW YORK, March 26, 2024 /PRNewswire/ -- Renowned triple board certified plastic surgeon Dr. Ramtin Kassir is thrilled to announce an exclusive three-day course on advanced facial rejuvenation techniques, set to refine surgical repertoires and transform practices. This premier educational event will take place in the vibrant heart of New York City from May 3rd through May 5th, providing participants with a unique opportunity to learn from one of the best in the field alongside distinguished international faculty.

Designed for surgeons eager to master the art and science of advanced facelifting techniques, this meticulously curated program offers an immersive experience aimed at enhancing expertise and delivering unparalleled patient outcomes. Participants will engage in hands-on cadaver dissections, in-depth discussions, and live demonstrations, all geared towards elevating skill sets and setting new standards in cosmetic surgery.

"We are excited to welcome participants to New York City for an educational experience like no other," said Dr. Kassir. "This course is specifically designed for surgeons who are looking to incorporate the latest advances in understanding facial anatomy into their aesthetic facial plastic surgery."

The course will cover a range of topics including Endoscopic Deep Plane Brow & Face Lift, Deep Plane Facelifting, and Lip Lifting. Through a guided, hands-on cadaver dissection program, participants will gain valuable insights into advanced and contemporary approaches to facial rejuvenation.

Expert Faculty Include:

Key learning objectives include:

The event will be held at Kassir Plastic Surgery, located at 65 East 66th Street, New York, New York 10065, from May 3rd to May 5th, 2024.

Registration rates are as follows:

Limited availability - to reserve your seat today, please register using this link or email [email protected]. Waiting lists are available for any cancellations or future courses.

For more information, including venue details and travel recommendations, please visit www.drkassir.com/course or contact [email protected].

About Dr. Ramtin Kassir:
Dr. Ramtin Kassir is a Triple Board Certified plastic surgeon renowned for his expertise in facial rejuvenation and cosmetic surgery. With a commitment to excellence and innovation, Dr. Kassir is dedicated to providing patients with natural-looking results tailored to their individual needs.

For media inquiries or interview requests, please contact:
Michelle Aselta
[email protected]

SOURCE Kassir Plastic Surgery


These press releases may also interest you

at 07:49
Lucid Diagnostics Inc.  ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and...

at 07:47
Junk food is so loved by many. What is not loved are the associated medical conditions and weight gain. Over time, scientific studies have been conducted at various institutions across America and abroad. These studies have indicated that fiber and...

at 07:35
Organon today announced its results for the first quarter ended March 31, 2024. "We entered this year with a clear focus: to deliver our 2024 financial targets while staying true to our mission of improving the health of women, and the first...

at 07:35
Lantern Pharma Inc. , an artificial intelligence ("AI") company developing targeted and transformative cancer therapies using its proprietary RADR® AI and machine learning ("ML") platform with multiple clinical stage drug programs, today announced...

at 07:30
Quipt Home Medical Corp. (the "Company") ?, a U.S. based home medical equipment provider, focused on end-to-end respiratory care, announced today that the Toronto Stock Exchange ("TSX") has accepted the Company's notice of intention to implement a...

at 07:30
Theratechnologies Inc. ("Theratechnologies" or the "Company") , a biopharmaceutical company focused on the development and commercialization of innovative therapies, today announced that it will present long-term efficacy, safety and...



News published on and distributed by: